Table 1.
Estimated Costs of Non-Invasive Tests ($USD) Cost-Accounting Sites, Premier Research Database* |
||||||
---|---|---|---|---|---|---|
N | Mean | Standard deviation | Median | 25th– 75th percentile | Minimum – Maximum | |
Pharm MPI | 3903 | $1132 | $416 | $1101 | $864 – $1356 | $432 – $4517 |
Exercise MPI | 2396 | $946 | $420 | $898 | $649 – $1189 | $280 – $3052 |
Pharm. Echo | 152 | $501 | $135 | $487 | $408 – $562 | $258 – $978 |
Exercise Echo | 632 | $514 | $151 | $508 | $403 – $612 | $238 – $1261 |
Exercise EKG | 455 | $174 | $80 | $152 | $117 – $196 | $61 – $465 |
CTA w/Contrast | 489 | $404 | $122 | $401 | $307 – $486 | $167 – $878 |
Estimated Costs of Non-Invasive Tests, by Cost Component ($USD) Cost-Accounting Sites, Premier Research Database* | ||||||
---|---|---|---|---|---|---|
Pharm Stress MPI (n=3903) |
Exercise Stress MPI (n=2396) |
Pharm Stress Echo (n=152) |
Exercise Stress Echo (n=632) |
Exercise EKG (n=455) |
CTA (n=489) |
|
Primary test (imaging, treadmill or CTA) | $502 | $538 | $210 | $252 | $137 | $221 |
Stress test | $137 | $134 | $157 | $160 | $0 | $0 |
Stress agent | $214 | $0 | $14 | $0 | $0 | $0 |
Isotope | $152 | $151 | $0 | $0 | $0 | $0 |
Contrast | $0 | $0 | $26 | $15 | $0 | $48 |
Lab | $1 | $1 | $1 | $1 | $0 | $6 |
Other pharm | $3 | $2 | $7 | $0 | $0 | $10 |
Other nuclear Medicine | $7 | $3 | $0 | $0 | $0 | $0 |
Subtotal | $1015 | $829 | $415 | $428 | $137 | $285 |
Physician fees** | $117 | $117 | $86 | $86 | $37 | $119 |
Total | $1132 | $946 | $501 | $514 | $174 | $404 |
CTA= computed tomography angiogram, Pharm=pharmacological, echo=echocardiogram, EKG=electrocardiogram, MPI=myocardial perfusion imaging
Difference in totals due to rounding.
Outpatient isolated test encounters between 1/1/2014 – 6/30/2014 with admission diagnosis=chest pain, or primary/secondary diagnosis of chest pain/acute coronary syndrome/ischemic heart disease/valve/dysrhythmias. Excludes 6 sites with inconsistent data.
Based on Medicare Fee Schedule